State of the Society. Intravenous Nurses Society.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
The Intravenous Nurses Society recognizes the inherent risks to the patient and the caregiver associated with the administration of antineoplastic agents. Individuals involved in the administration of these agents should have specialty education and validation of competency on a continuum and be licensed as a physician or a registered nurse.
The Intravenous Nurses Society (INS) recognizes the use of unlicensed assistive personnel in nursing. The Society believes unlicensed assistive personnel may assist the registered nurse in preparing equipment and recording statistics; however, to ensure that safe, quality nursing care is provided to all patients receiving infusion therapies, the Intravenous Nurses Society strongly recommends that unlicensed assistive personnel not be used in the role of delivering intravenous therapy.
The Intravenous Nurses Society contends that intravenous nurse specialists should be involved wherever infusion therapies are delivered. Although the evolving health care environment has led to an increased number of practice settings, the need for quality patient care is still paramount. Intravenous nurse specialists have the skill and expertise to ensure competent practice, as well as the ability to keep costs down.
The Intravenous Nurses Society recognizes the importance of engineering and work practice controls to minimize or eliminate occupational exposure to bloodborne pathogens. However, such controls must be carefully balanced to maximize patient care and minimize personnel risk. Decisions regarding the development, selection, and use of such products must take into consideration: patient safety, desired therapeutic outcomes, ethical considerations, effective use of resources and cost, and practitioner protection.
The Intravenous Nurses Society (INS) contends that registered intravenous nurses should be involved in the purchasing decisions of vascular access devices. Because nurses are the end-users of these products, they have knowledge on the quality and reliability of intravenous therapy products. Although cost containment concerns are paramount, cost should not be the only criteria observed in making purchasing decisions.
The Intravenous Nurses Society (INS) contends that registered intravenous nurses as the ultimate end-users of vascular access devices are the most qualified individuals for the selection of these products. Although the physician is responsible for initiating orders, nurses are the most appropriate health care providers for determining the correct vascular access product to be used to deliver the ordered therapies.
The Intravenous Nurses Society (INS) believes that the intravenous trained licensed practical nurse and the licensed vocational nurse can aid in the delivery of some aspects of intravenous therapy under the supervision of the registered nurse; however, the registered nurse shall be the primary practitioner in this specialty.
The Intravenous Nurses Society (INS) recognizes the need for uniform terminology for peripherally inserted central catheters (PICCs) to encourage standardization for indications, care, and maintenance strategies for these devices. It also recognizes the need for recommendations regarding the choice, use, management, and discontinuation of PICCs to promote positive patient outcomes and enhance patient comfort, safety, and satisfaction.
The Intravenous Nurses Society (INS) recognizes the need for uniform terminology for midline and midclavicular catheters to encourage standardization for indications, care, and maintenance strategies for these devices. It also recognizes the need for recommendations regarding the choice, use, management, and discontinuation of midline and midclavicular catheters to promote positive patient outcomes and enhance patient comfort, safety, and satisfaction.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Growing interest in peripherally inserted intravenous catheters led to the development of the PICC Council. This council was established to provide a resource of information for the area nurses involved in peripherally inserted intravenous catheters use and care. The group went through various developmental stages as they sought to establish cohesiveness and professional collaboration across a variety of practice settings. The outcome was the development of recommendations for vocabulary, communication, and care/maintenance activities, that could be used by intravenous nurses to enhance patient care coordination.
This article explores three major health reform questions: (1) Why do we need to reform a system that provides cutting-edge healthcare? (2) What are the consequences of inaction? (3) Why is it so difficult to carry out a reform that has the support of most Americans? Based on the answers to these three questions, the article offers a two-prong reform alternative. First, seek a national consensus on why we disagree on healthcare. Second, let the states experiment with several promising and competing reform plans before committing to a national level reform.
Explore the source record for details and available documents.
There is no single task that nurses do more often than make decisions, yet many clinicians feel inadequately prepared to address and resolve ethical issues. The Intravenous Nurses Society Code of Ethics provides practice guidelines for intravenous nursing specialists who need to make these often difficult decisions. The availability of an ethical decision-making model can assist the IV nurse in providing ethical quality care, regardless of the clinical setting in which care is delivered.
Many authors demonstrate the cost effectiveness of using intravenous teams to provide quality venous access care. Despite this evidence, many hospitals are dissolving their i.v. teams as a way of cutting costs. This article provides a guide for downsizing while maintaining quality i.v. therapy. The article chronicles events before and after the disbanding of the i.v. team of the San Francisco Veteran's Administration Medical Center. The focus of the article demonstrates how creating two advanced practice positions is instrumental to maintaining quality i.v. care. Quality is defined as line-associated bacteriemia rates and compliance rates to i.v. care standards, remaining unchanged or better after the downsizing of the i.v. team. Line-associated bacteriemia rates are presented in terms of infections per 1000 line days when possible. Compliance percentages are obtained by auditing compliance to site changes, central line policy. The data are provided in chart form, and definitely show a sharp decline in line-associated bacteremias after the advent of the i.v. clinician role. These data provide clear evidence to support the Intravenous Nurses Society position on the role of the intravenous nurse specialist. Conclusions emphasize the need for i.v. nurse clinicians to provide critical care coverage, ongoing educational programs, outcome auditing, and nursing research in vascular access and i.v. therapy.
The Great Lakes Chapter of the Intravenous Nurses Society developed a scholarship program to reward members for participation in INS activities and to promote the INS goals of education and knowledge sharing. Scholarships were awarded for holding office or committee work, educational activities or authorship, meeting attendance and recruitment efforts, and certification/recognition by INS. This article describes the point system used for awarding scholarships, program funding, and pitfalls in the program.